SCHEMBL7653536

SCHEMBL7653536

N=C(N)c1ccc(NC(=O)c2ccccc2-c2ccccc2OP(=O)(O)O)cc1

nearest known ligand 0.57

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
F10 P00742 10/20 0.57
F2 P00734 9/20 0.57
PLAU P00749 8/20 0.57
PLAT P00750 8/20 0.57
PLG P00747 4/20 0.57
KLK1 P06870 5/20 0.56
KLK5 Q9Y337 5/20 0.56
PRSS1 P07477 3/20 0.51
PRSS2 P07478 3/20 0.51
PRSS3 P35030 3/20 0.51
F7 P08709 1/20 0.51
F3 P13726 1/20 0.51
CYP3A4 P08684 1/20 0.45
CYP2C9 P11712 1/20 0.45
ALOX12 P18054 1/20 0.45
ST14 Q9Y5Y6 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7665910 0.94 KLK1 (0.54) F10F2PLAUPLATPLG
SCHEMBL7659161 0.81 PLAU (0.60) F10F2PLAUPLATPLG
SCHEMBL7653539 0.81 PLAU (0.68) F10F2PLAUPLATPLG
SCHEMBL7661930 0.81 CYP3A4 (0.69) F10F2PLAUPLATPLG
Hydrochloric Acid SCHEMBL7655131 0.80 CYP3A4 (0.68) F10F2PLAUPLATPLG
Hydrochloric Acid SCHEMBL7654805 0.79 PLAU (0.61) F10F2PLAUPLATPLG
SCHEMBL7656788 0.78 KLK1 (0.68) F10F2PLAUPLATPLG
SCHEMBL7654641 0.77 KLK1 (0.54) F10F2PLAUPLATPLG
SCHEMBL7660234 0.77 PLAU (0.66) F10F2PLAUPLATPLG
SCHEMBL7662316 0.76 KLK1 (0.53) F10F2PLAUPLATPLG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6358960-B1 FOR THERAPY OF INTRAVASCULAR COAGULATION, CORONARY THROMBOSIS, CEREBRAL INFARCTION, CEREBRAL EMBOLISM, TRANSIENT ISCHEMIC ATTACK, CEREBROVASCULAR DISORDERS, PULMONARY VASCULAR DISEASES, DEEP VENOUS THROMBOSIS, ETC. ONO PHARMACEUTICAL CO., LTD. (JP) 2002-03-19 US claimed
EP-1078917-A1 AMIDINO DERIVATIVES AND DRUGS CONTAINING THE SAME AS THE ACTIVE INGREDIENT ONO PHARMACEUTICAL CO., LTD. (JP) 2001-02-28 EP claimed
US-6358960-B1 FOR THERAPY OF INTRAVASCULAR COAGULATION, CORONARY THROMBOSIS, CEREBRAL INFARCTION, CEREBRAL EMBOLISM, TRANSIENT ISCHEMIC ATTACK, CEREBROVASCULAR DISORDERS, PULMONARY VASCULAR DISEASES, DEEP VENOUS THROMBOSIS, ETC. ONO PHARMACEUTICAL CO., LTD. (JP) 2002-03-19 US disclosed
EP-1078917-A1 AMIDINO DERIVATIVES AND DRUGS CONTAINING THE SAME AS THE ACTIVE INGREDIENT ONO PHARMACEUTICAL CO., LTD. (JP) 2001-02-28 EP disclosed